Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lofton-Day

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Digestive Diseases (Basel, Switzerland)|January 31, 2004
DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic toolsCatherine Lofton-Day, Ralf Lesche
The Journal of Molecular Diagnostics : JMD|December 21, 2016
Diagnostic Quality Assurance Pilot: A Model to Demonstrate Comparative Laboratory Test Performance with an Oncology Companion Diagnostic AssayBarbara Zehnbauer, Catherine Lofton-Day, John Pfeifer, et al.
American Journal of Clinical Pathology|December 6, 2021
Reference Samples to Compare Next-Generation Sequencing Test Performance for Oncology Therapeutics and DiagnosticsJohn D Pfeifer, Robert Loberg, Catherine Lofton-Day, et al.
The International Journal of Biochemistry & Cell Biology|May 15, 2007
Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisationJoern Lewin, Achim Plum, Thomas Hildmann, et al.
Cancer Research|May 31, 2002
Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cellsHuidong Shi, Pearlly S Yan, Chuan-Mu Chen, et al.
Plos One|February 9, 2010
Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesionsMarc Tänzer, Benjamin Balluff, Jürgen Distler, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancersMatthias P A Ebert, Suzanne H Mooney, Lori Tonnes-Priddy, et al.
Journal of Cancer Research and Clinical Oncology|July 19, 2018
Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME studyNitin Udar, Catherine Lofton-Day, Jun Dong, et al.
Clinical Chemistry|December 20, 2007
DNA methylation biomarkers for blood-based colorectal cancer screeningCatherine Lofton-Day, Fabian Model, Theo Devos, et al.
Gastroenterology|November 15, 2006
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomasMatthias P A Ebert, Fabian Model, Suzanne Mooney, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Digestive Diseases (Basel, Switzerland)|January 31, 2004
DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic toolsCatherine Lofton-Day, Ralf Lesche
The Journal of Molecular Diagnostics : JMD|December 21, 2016
Diagnostic Quality Assurance Pilot: A Model to Demonstrate Comparative Laboratory Test Performance with an Oncology Companion Diagnostic AssayBarbara Zehnbauer, Catherine Lofton-Day, John Pfeifer, et al.
American Journal of Clinical Pathology|December 6, 2021
Reference Samples to Compare Next-Generation Sequencing Test Performance for Oncology Therapeutics and DiagnosticsJohn D Pfeifer, Robert Loberg, Catherine Lofton-Day, et al.
The International Journal of Biochemistry & Cell Biology|May 15, 2007
Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisationJoern Lewin, Achim Plum, Thomas Hildmann, et al.
Cancer Research|May 31, 2002
Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cellsHuidong Shi, Pearlly S Yan, Chuan-Mu Chen, et al.
Plos One|February 9, 2010
Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesionsMarc Tänzer, Benjamin Balluff, Jürgen Distler, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancersMatthias P A Ebert, Suzanne H Mooney, Lori Tonnes-Priddy, et al.
Journal of Cancer Research and Clinical Oncology|July 19, 2018
Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME studyNitin Udar, Catherine Lofton-Day, Jun Dong, et al.
Clinical Chemistry|December 20, 2007
DNA methylation biomarkers for blood-based colorectal cancer screeningCatherine Lofton-Day, Fabian Model, Theo Devos, et al.
Gastroenterology|November 15, 2006
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomasMatthias P A Ebert, Fabian Model, Suzanne Mooney, et al.
Pageof 2